Lipids and Cardiovascular Risk with CKD

被引：14
|
作者：
Afshinnia, Farsad [1 ]
Pennathur, Subramaniam [1 ,2 ]
机构：
[1] Univ Michigan, Dept Internal Med Nephrol, 1000 Wall St, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 01期
关键词：
chronic kidney disease; cardiovascular disease; lipids; humans; HDL cholesterol; LDL cholesterol; LDL lipoproteins; IDL lipoproteins; metabolic syndrome; chylomicrons; monocytes; cardiovascular diseases; insulin resistance; carrier proteins; cytokines; cholesterol; triglycerides; VLDL lipoproteins; atherosclerosis; dyslipidemias; apolipoproteins; obesity; macrophages; proteinuria; chronic renal insufficiency; DISEASE;
D O I：
10.2215/CJN.13531119
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [1] Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
    Bajaj, Archna
    Xie, Dawei
    Cedillo-Couvert, Esteban
    Charleston, Jeanne
    Chen, Jing
    Deo, Rajat
    Feldman, Harold, I
    Go, Alan S.
    He, Jiang
    Horwitz, Edward
    Kallem, Radhakrishna
    Rahman, Mahboob
    Weir, Matthew R.
    Anderson, Amanda H.
    Rader, Daniel J.
    Appel, Lawrence J.
    Kusek, John W.
    Lash, James P.
    Rao, Panduranga S.
    Townsend, Raymond R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (06) : 827 - 836
  • [2] Cardiovascular Risk Prediction in CKD
    Ballew, Shoshana H.
    Matsushita, Kunihiro
    SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 208 - 216
  • [3] The role of lipids and uremic toxins in cardiovascular disease in CKD
    Ziad A. Massy
    Clinical and Experimental Nephrology, 2014, 18 : 255 - 256
  • [4] The role of lipids and uremic toxins in cardiovascular disease in CKD
    Massy, Ziad A.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 255 - 256
  • [5] CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD
    Park, Jongha
    JOURNAL OF HYPERTENSION, 2016, 34 : E544 - E545
  • [6] Advancing Understanding of Cardiovascular Risk in CKD
    Sridhar, Vikas S.
    Odutayo, Ayodele
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 36 (02): : 171 - 173
  • [7] Lipids, cardiovascular risk factors
    Delahaye, F
    de Gevigney, G
    NEPHROLOGIE, 2000, 21 (07): : 319 - 321
  • [8] ANDROGENS, LIPIDS, AND CARDIOVASCULAR RISK
    PLYMATE, SR
    SWERDLOFF, RS
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (10) : 871 - 872
  • [9] Metabolic Acidosis and Cardiovascular Disease Risk in CKD
    Abramowitz, Matthew K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1451 - 1452
  • [10] Candidate risk factors for cardiovascular disease in CKD
    De Santo, NG
    Cirillo, M
    Perna, A
    Iacono, G
    Capasso, G
    SEMINARS IN NEPHROLOGY, 2006, 26 (01) : 1 - 2
12345